# Adherenceside

*/Startups/Adherenceside*

## Startup Overview

This software validates patient medication intake using standard smartphone camera feeds. It operates without requiring specialized tracking devices, transforming any patient's existing mobile phone into a clinical adherence monitor. The system identifies the specific pill and verifies the physical act of consumption, logging exact timestamps to ensure strict dosage compliance.

Clinical trial sponsors and specialty care providers face consistent gaps in treatment data due to unreliable patient self-reporting. Traditional validation methods either rely on subjective memory logs or force providers to distribute physical tracking hardware like Bluetooth smart bottles to every participant. This hardware dependency drives up deployment costs and creates severe logistical friction when devices break, lose battery, or fail to sync.

Unlike smart bottles that only track lid removal, or legacy platforms like AiCure that demand complex user interactions, this system is completely hardware-free and passive for the end patient. Individuals simply take their medication in view of their device while the computer vision layer processes the validation in the background. This removes the burden of manual data entry and hardware management while delivering high-fidelity adherence records directly to clinical teams.

## Startup Founding Hypothesis

**Approach**: that validates medication intake through smartphone camera feeds
**Competitors**:
- [Bluetooth Smart Bottles](/Competitors/Bluetooth_Smart_Bottles)
- [AiCure](/Competitors/AiCure)
- [Patient Self-Reporting](/Competitors/Patient_Self-Reporting)
**Differentiator2x2**: hardware-free and completely passive for the end patient

## Startup Solution Coordinate

**Solution**: [Adherence Lens](/Software/Adherence_Lens)

## Startup Position2x2

```mermaid
quadrantChart
    title Medication Adherence Tracking Landscape
    x-axis "Dedicated Hardware Required" --> "Hardware-Free"
    y-axis "Active Patient Effort" --> "Completely Passive"
    quadrant-1 "Ideal Experience"
    quadrant-2 "Costly Convenience"
    quadrant-3 "Legacy Friction"
    quadrant-4 "Digital Burden"
    Adherenceside: [0.88, 0.85]
    Bluetooth Smart Bottles: [0.15, 0.80]
    AiCure: [0.80, 0.25]
    Patient Self-Reporting: [0.95, 0.10]
```

## Startup Offer

**Proof**:
- Aim to detect 98% of oral solid intake events under standard home lighting.
- Targeting zero hardware deployment costs for remote clinical trial coordinators.
- Designed to eliminate false-positive adherence logs by replacing self-reporting with passive camera verification.
**Tiers**:
- Name: Developer API · Price: ~$0.10–$0.25 per validation event · Inclusions: API access for computer-vision intake validation, capped at 500 active testing profiles, standard oral solid recognition models.
- Name: Clinical Cohort · Price: ~$25–$45/patient/mo · Inclusions: Unlimited validation events for up to 1,000 active patients, HIPAA-compliant audit logging, and clinician dashboard access.
- Name: Trial Enterprise · Price: enterprise: ~$60k–$100k/yr · Inclusions: Dedicated processing infrastructure designed for 21 CFR Part 11 compliance, covering up to 5,000 patients across multiple remote trial sites.
**Guarantee**: If the computer vision pipeline fails to classify a clear, unobstructed intake event within 5 seconds of the frame capture, that validation run is credited back to the monthly invoice.
**Business Function**: ProvideService
**Objection Handlers**:
- Privacy of home video feeds? Processing is designed to blur faces on-device, transmitting only the isolated medication and mouth interaction.
- What if the patient is in poor lighting? The interface actively measures ambient lux and prompts the patient to adjust lighting before capturing.
- Does it require the newest smartphones? The system is designed to run edge-inference models on standard mid-tier iOS and Android devices.
- How does it handle complex pill regimens? The vision model is trained to count and verify standard pill geometries, logging discrepancies against the prescription.
**Pricing Architecture**: Tiered
**Agent Checkout Support**:
- agentic-commerce-protocol

## Startup Brand

**Voice**: Authoritative and clear, prioritizing exact clinical instruction over technical jargon.
**Tagline**: Passive medication verification through standard smartphone cameras.
**Icon Concept**: capsule
**Palette Intent**: institutional-cool
**Visual Identity**: Clinical slate blues and sterile whites pair with crisp macro photography of medications to project pharmaceutical rigor.
**Archetype Reference**: the-sage

## Startup Buyer Chain

**Chain**: Startup → Clinical Trial Sponsor → Trial Participant
**Gtm Motion**: Direct outbound sales targeting Clinical Operations Directors at pharma sponsors to land a software pilot on a single Phase II trial. Expansion is driven by validating the data collection method on the initial cohort, then rolling out the camera-based endpoint across the sponsor's broader clinical trial portfolio.
**Agent Channel**: Designed for inclusion in clinical protocol-builder registries, allowing healthcare AI agents to automatically query and embed the medication validation API endpoint when autonomously drafting decentralized trial requirements.
**Primary Channel**: Targeted outbound and intended vendor listings in Decentralized Clinical Trial (DCT) partner networks, where trial sponsors and Contract Research Organizations search for hardware-free adherence solutions during the protocol design phase.

## Startup Customer Journey

```mermaid
flowchart LR A[DCT Partner Network] --> B[Developer API Documentation] --> C[Single Trial Pilot] --> D[First Intake Verification] --> E[Clinical Cohort] --> F[Enterprise Trial Infrastructure] --> G[Sponsor Portfolio]
```

## Startup Proof Points

_Illustrative — target and order-of-magnitude estimate figures, not an achieved track record (this Thing is concept-stage)._

**Pilot Goals**:
- 30-day usability pilot with 50 remote patients: Aims to prove the edge-inference model operates seamlessly on mid-tier Android and iOS devices without usability friction.
- 60-day parallel tracking pilot alongside a traditional Phase II trial: Aims to demonstrate a measurable reduction in false-positive adherence logs compared to standard self-reporting.
**Target Metrics**:
- Target: 98 percent detection accuracy for oral solid intake events under standard home lighting.
- Aim: Zero dollars in hardware deployment costs for remote clinical cohorts.
- Target: Sub-5-second classification latency for unobstructed intake frame captures.
- Aim: Zero instances of unblurred facial data transmitted to remote servers.
**Target Case Studies**:
- Mid-sized Contract Research Organization Trial Coordinator: Shifts from relying on patient self-reported medication diaries with high error rates to passive smartphone camera verification that flags missed doses instantly.
- Phase III Pharmaceutical Sponsor Director: Transitions from shipping expensive proprietary hardware to trial participants to deploying a zero-hardware-cost edge-inference application on patient-owned devices.
- Decentralized Clinical Trial Product Manager: Replaces custom-built adherence tracking with an integrated computer vision API that delivers 21 CFR Part 11 compliant audit logging out of the box.
**Testimonial Targets**:
- Clinical Trial Coordinator: Relief that passive camera verification eliminates the need to manually cross-reference patient diaries and call patients about missed doses.
- Pharmaceutical Trial Director: Confidence that the ambient lux measurement and on-device processing ensure high-quality compliance data without compromising trial timelines.
- Remote Trial Compliance Officer: Assurance that local face-blurring and strict audit logging satisfy stringent trial privacy mandates.

## Startup Top Risks

**Risks**:
- Severity: existential · Description: Patients and healthcare regulators reject passive background smartphone camera access due to severe privacy and continuous surveillance concerns. · Mitigation Status: unmitigated
- Severity: existential · Description: The completely passive differentiator fails because patients keep their phones in pockets or out of sight during medication intake, blinding the camera feed. · Mitigation Status: in-progress
- Severity: high · Description: Continuous background video processing drains the smartphone battery rapidly, prompting the operating system to kill the process or users to uninstall the application. · Mitigation Status: in-progress
- Severity: moderate · Description: The computer vision model fails to reliably distinguish between actual ingestion and simulated ingestion or generic hand-to-mouth movements. · Mitigation Status: unmitigated

## Startup Competitors

- [Bluetooth Smart Bottles](/Competitors/Bluetooth_Smart_Bottles) — Hardware
- [AiCure](/Competitors/AiCure) — Incumbent
- [Patient Self-Reporting](/Competitors/Patient_Self-Reporting) — Status Quo
- [Emocha Health](/Competitors/Emocha_Health) — Video DOT App
- [Medisafe App](/Competitors/Medisafe_App) — Manual Tracking

## Startup Solution Stack

- [Intake Validation Service](/Services/Intake_Validation_Service) — Service-as-Software
- [Swallow Detection Agent](/Agents/Swallow_Detection_Agent) — Agent
- [Pill Recognition Agent](/Agents/Pill_Recognition_Agent) — Agent
- [Camera Feed SDK](/Software/Camera_Feed_SDK) — Software
- [Computer Vision API](/Software/Computer_Vision_API) — Software

## Startup Story Brand

**Hero**:
- **Need**: to deliver rigorous, audit-ready adherence data that withstands FDA scrutiny during trial analysis
- **Want**: to verify medication intake without shipping expensive hardware or relying on patient diaries
- **Identity**: the remote clinical trial coordinator managing patient adherence protocols
**Plan**:
- Step: Select · Detail: Define your medication geometries and dosing schedule within the Clinician Dashboard.
- Step: Audit · Detail: Review incoming intake validations through the HIPAA-compliant log to verify patient compliance in real-time.
- Step: Export · Detail: Generate 21 CFR Part 11 compliant reports for your final trial data package.
**Guide**:
- **Empathy**: You shouldn't still be chasing missing diary entries. AiCure and smart bottles wasn't built to scale across global cohorts without massive hardware overhead.
**Problem**:
- **Villain**: self-reporting bias
- **External**: relying on patient diaries or Bluetooth smart bottles leads to missing data and manual query resolution in the EDC
- **Internal**: you feel anxious that unverified dosing is quietly compromising the integrity of your entire study
- **Philosophical**: Every trial coordinator deserves clinical-grade evidence — not the guesswork of an unchecked honor system.
**Success**: Your study achieves 98% adherence visibility with zero hardware deployment and fully automated audit logs.
**One Liner**: Every month, clinical trial coordinators lose data to unreliable diaries. Adherenceside validates intake through smartphone cameras so trials get hardware-free, audit-ready compliance.
**Positioning**:
- **So That**: verify patient dosing without shipping specialized hardware
- **Unlike**: Bluetooth smart bottles
- **For Whom**: remote clinical trial coordinators
- **Category**: Computer vision medication verification
**Call To Action**:
- **Direct**: Launch clinical cohort
- **Transitional**: Review API documentation
**Failure Stakes**:
- Compromised trial data integrity
- Unnecessary hardware shipping costs
- Regulatory rejection of self-reported data
**Transformation**:
- **To**: the clinical study's verification authority
- **From**: a trial coordinator chasing patient diary updates
**Controlling Idea**: Clinical medication adherence belongs in the camera lens, not on paper.

## Startup Token Hero

**Genre**: founding-hypothesis
**Rendered**: Every month, clinical trial coordinators lose data to unreliable diaries. Adherenceside validates intake through smartphone cameras so trials get hardware-free, audit-ready compliance.
**Mechanism**: spine-derived-v1
**Template Id**: spine-founding-hypothesis
**Vocab Fingerprint**: 384118c3460fa8fd

## Startup Token Positioning

**Genre**: moore-positioning
**Rendered**: Computer vision medication verification for remote clinical trial coordinators. Unlike Bluetooth smart bottles — verify patient dosing without shipping specialized hardware.
**Mechanism**: spine-derived-v1
**Template Id**: spine-moore-positioning
**Vocab Fingerprint**: 73c02fd14b1a74e2

## Startup Token Pitch Deck

**Genre**: pitch-deck
**Rendered**: Problem: relying on patient diaries or Bluetooth smart bottles leads to missing data and manual query resolution in the EDC
Solution: Every month, clinical trial coordinators lose data to unreliable diaries. Adherenceside validates intake through smartphone cameras so trials get hardware-free, audit-ready compliance.
Customer: remote clinical trial coordinators
Unlike: Bluetooth smart bottles
**Mechanism**: spine-derived-v1
**Template Id**: spine-pitch-deck
**Vocab Fingerprint**: deccb3d0b3d2ca08

## Startup Token M E D D P I C C

**Pain**: relying on patient diaries or Bluetooth smart bottles leads to missing data and manual query resolution in the EDC
**Metrics**: Target: Your study achieves 98% adherence visibility with zero hardware deployment and fully automated audit logs.
**Rendered**: Pain: relying on patient diaries or Bluetooth smart bottles leads to missing data and manual query resolution in the EDC
Economic buyer: Clinical Trial Sponsor
Metrics: Target: Your study achieves 98% adherence visibility with zero hardware deployment and fully automated audit logs.
Competition: Bluetooth smart bottles
**Mechanism**: spine-derived-v1
**Competition**: Bluetooth smart bottles
**Economic Buyer**: Clinical Trial Sponsor
**Vocab Fingerprint**: 085364d079ad3f3e

## Startup Token Cold Email

**Genre**: cold-email
**Rendered**: Subject: Computer vision medication verification for remote clinical trial coordinators

remote clinical trial coordinators — relying on patient diaries or Bluetooth smart bottles leads to missing data and manual query resolution in the EDC Every month, clinical trial coordinators lose data to unreliable diaries. Adherenceside validates intake through smartphone cameras so trials get hardware-free, audit-ready compliance.
**Mechanism**: spine-derived-v1
**Template Id**: spine-cold-email
**Vocab Fingerprint**: a596b41b9c782806

## Startup Token Agent Spec

**Genre**: ai-agent-spec
**Rendered**: Computer vision medication verification. Every month, clinical trial coordinators lose data to unreliable diaries. Adherenceside validates intake through smartphone cameras so trials get hardware-free, audit-ready compliance. Serves remote clinical trial coordinators.
**Mechanism**: spine-derived-v1
**Template Id**: spine-ai-agent-spec
**Vocab Fingerprint**: c553a6b2e96b008e

## Neighborhood

### Candidate solutions

- [Annual Tax Code Adherence](/Problems/Annual_Tax_Code_Adherence) — candidate solution for · Problems

### Composed of

- [Camera Feed SDK](/Software/Camera_Feed_SDK) — composes · Software
- [Intake Validation Service](/Services/Intake_Validation_Service) — composes · Services
- [Pill Recognition Agent](/Agents/Pill_Recognition_Agent) — composes · Agents
- [Computer Vision API](/Software/Computer_Vision_API) — composes · Software
- [Swallow Detection Agent](/Agents/Swallow_Detection_Agent) — composes · Agents

### Embodies

- [Software](/Theses/Software) — embodies · Theses

### What it offers

- [Adherence Lens](/Software/Adherence_Lens) — offers · Software

### Competitors

- [Bluetooth Smart Bottles](/Competitors/Bluetooth_Smart_Bottles) — competes with · Competitors
- [Medisafe App](/Competitors/Medisafe_App) — competes with · Competitors
- [Emocha Health](/Competitors/Emocha_Health) — competes with · Competitors
- [Patient Self-Reporting](/Competitors/Patient_Self-Reporting) — competes with · Competitors
- [AiCure](/Competitors/AiCure) — competes with · Competitors

### Similar Startups

- [Vitade](/Startups/Vitade) — similar · Startups
- [Adherenceshed](/Startups/Adherenceshed) — similar · Startups
- [Bodyridge](/Startups/Bodyridge) — similar · Startups
- [Medanager](/Startups/Medanager) — similar · Startups
- [Adherenceoperators](/Startups/Adherenceoperators) — similar · Startups
- [Trialtone](/Startups/Trialtone) — similar · Startups
- [Truegrove](/Occupations/Miscellaneous_Health_Technologists_and_Technicians/Problems/Diagnostic_Equipment_Calibration_Audits/Startups/Truegrove) — similar · Startups
- [Chronichaven](/Startups/Chronichaven) — similar · Startups
- [Rehabilitateguild](/Startups/Rehabilitateguild) — similar · Startups
- [Thrivevessel](/Startups/Thrivevessel) — similar · Startups
- [Outpidge](/Occupations/Occupational_Therapy_Assistants_and_Aides/Problems/Therapy_Plan_Abandonment/Startups/Outpidge) — similar · Startups
- [Loanweave](/CompanyTypes/Digital-First_D2C_Apparel_Brand/JobTypes/Apparel_Showroom_Sales_Rep/Problems/Showroom_Sample_Tracking/Startups/Loanweave) — similar · Startups
- [Adherencyard](/Problems/Immunotherapy_Patient_Adherence/Startups/Adherencyard) — similar · Startups
- [Audequipment](/Startups/Audequipment) — similar · Startups
- [Priment](/Occupations/Occupational_Therapy_Assistants_and_Aides/Problems/Therapy_Plan_Abandonment/Startups/Priment) — similar · Startups
- [Beacechanics](/Startups/Beacechanics) — similar · Startups
- [Luminouspatient](/Startups/Luminouspatient) — similar · Startups
- [Chronicmark](/Startups/Chronicmark) — similar · Startups
- [Acutetube](/Startups/Acutetube) — similar · Startups
- [Accare](/Startups/Accare) — similar · Startups